Brain Diseases Clinical Trial
— ExploreBPETOfficial title:
Exploratory Study of BPET, an Investigational Medical Device Without CE-marking for PET Imaging of the Human Brain
NCT number | NCT04511546 |
Other study ID # | 001 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | October 27, 2020 |
Est. completion date | March 5, 2021 |
Verified date | March 2021 |
Source | Positrigo AG |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The "BPET prototype" is a small aperture PET scanner. The BPET prototype will be used with patients, which have just finished their regularly scheduled PET examination on a clinical whole body PET system. The radioactive tracer used for this procedure will still be active. This remaining acitivity will be used for an image acquisition with the BPET prototype without the need for an additional radioactive tracer dose. The control intervention is be a brain PET scan as part of standard clinical routine. It will be done immediately before the scan on the BPET prototype.
Status | Completed |
Enrollment | 10 |
Est. completion date | March 5, 2021 |
Est. primary completion date | March 5, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - Capable of giving Informed Consent as documented by signature (Appendix Informed Consent Form) - ability to sit still in the head-only PET scanner for 15 minutes - Are scheduled to receive a regular brain PET scan as part of clinical routine. - Male and Female patients 18 years to 80 years of age Exclusion Criteria: - Contraindications to PET examination, - Patient height smaller than 160 cm or taller than 200 cm, - Patient weight more than 120 kg, - Patient cannot sit upright for at least 15 minutes, - Metal implants in the head, - Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, severe dementia, etc. of the participant, - Participation in another study with investigational drug/device within the 30 days preceding and during the present study, - Previous enrolment into the current study, - Enrolment of the investigator, his/her family members, employees and other dependent persons. |
Country | Name | City | State |
---|---|---|---|
Switzerland | PET Center Schlieren | Schlieren | ZH |
Lead Sponsor | Collaborator |
---|---|
Positrigo AG | University of Zurich |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Assessment of adverse events | Safety of the procedure will be assessed by documenting adverse events (description of the adverse events, number of participants) | During the imaging procedure which should last 15 minutes. | |
Other | Assessment of device deficiencies | Safety of the procedure will be assessed by documenting device deficiencies (description of the deficiency). | During the imaging procedure which should last 15 minutes. | |
Other | Identification of new risks | Safety of the procedure will be assessed by identifying and documenting any new risk. | During the imaging procedure which should last 15 minutes. | |
Primary | PET image of the brain | The primary outcome will be a PET image of the brain for each participant taken on BPET. It will be compared against the image taken by the conventional PET machine by a trained physician and judged by whether it could be used for diagnosis and further analysis. | 1 day | |
Secondary | Usability (patient feedback for seat comfort) | The secondary outcome with respect to usability will be feedback from patients with respect to patient seat comfort. | 1 day | |
Secondary | Usability (medical technologist feedback for ease of positioning) | The secondary outcome with respect to usability will be feedback from medical technologist with respect to easiness of patient positioning. | 1 day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05378035 -
DOAC in Chinese Patients With Atrial Fibrillation
|
||
Completed |
NCT05080777 -
Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care Systems
|
N/A | |
Recruiting |
NCT06186024 -
A PROSPECTIVE, MULTICENTER, SINGLE-ARM TRIAL FOR THE NEW SIZES OF BRIDGE STENTS FOR VERTEBRAL ARTERY STENOSIS: Bridge-MAX
|
N/A | |
Completed |
NCT06073145 -
Transcranial Doppler Using Wearable Ultrasound Patch
|
||
Completed |
NCT03295786 -
Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease
|
Phase 1/Phase 2 | |
Recruiting |
NCT06010823 -
Safety and Efficacy Evaluation of the Robotic Enhanced Error Training of Upper Limb Function in Post-stroke and Post TBI Participants
|
N/A | |
Completed |
NCT01915368 -
Determining Optimal Post-Stroke Exercise (DOSE)
|
N/A | |
Completed |
NCT02889939 -
High-intensity Training in an Enriched Environment in Late Phase After Stroke
|
N/A | |
Recruiting |
NCT05443542 -
VIrtual Reality in Cognitive Rehabilitation of Processing Speed for Persons With ABI
|
N/A | |
Active, not recruiting |
NCT03911388 -
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
|
Phase 1 | |
Completed |
NCT03994822 -
pRESET for Occlusive Stroke Treatment
|
N/A | |
Recruiting |
NCT06189950 -
Registration Trial of the Intracranial Visualized Stent for the Wide-necked Intracranial Aneurysms:REBRIDGE
|
N/A | |
Completed |
NCT04283253 -
Predictors of Response in Chronic Stroke
|
N/A | |
Recruiting |
NCT05578300 -
Effective Translation of Endovascular Thrombectomy Trials Into Real-world Practice in the Asia-Pacific
|
||
Completed |
NCT05815836 -
Precision Medicine in Stroke
|
||
Completed |
NCT02776189 -
Dexmedetomidine Verses Propofol for Paediatric MRI Brain
|
Phase 4 | |
Completed |
NCT00829361 -
Stroke Telemedicine for Arizona Rural Residents Trial
|
N/A | |
Recruiting |
NCT03678194 -
Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application
|
N/A | |
Recruiting |
NCT05048680 -
Effect of Hypoxic Conditioning on Cerebrovascular Health in the Elderly
|
N/A | |
Recruiting |
NCT04742920 -
The Onyx™ Trial For The Embolization Of The Middle Meningeal Artery For Chronic Subdural Hematoma (OTEMACS)
|
N/A |